skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Guidelines for the treatment of bacterial vaginosis: focus on tinidazole

Review

(3027) Views  (1124) Full article downloads

Authors: Laura J Dickey, Michael D Nailor, Jack D Sobel

Published Date June 2009 Volume 2009:5 Pages 485 - 489
DOI: http://dx.doi.org/10.2147/TCRM.S3777

Laura J Dickey1, Michael D Nailor2,3, Jack D Sobel4

1Department of Pharmacy Services, Detroit Receiving Hospital, Detroit, MI, USA; 2University of Connecticut, School of Pharmacy, Storrs, CT, USA; 3Hartford Hospital, Department of Pharmacy, Hartford, CT, USA; 4Wayne State University, School of Medicine, Detroit, MI, USA

Abstract: Bacterial vaginosis (BV) is a complex vaginal infection most commonly associated with women of child-bearing age. Risk factors for BV are numerous. There are currently multiple clinical and laboratory tests for diagnosis of BV, including the most commonly used diagnostic methods: Amsel’s criteria or Nugent’s Gram stain scale. The mainstay of BV therapy is metronidazole, but tinidazole as well as a few other agents have also been used successfully. Tinidazole is the second nitroimidazole antiprotozoal agent and a structural derivative of metronidazole. With a favorable pharmacokinetic profile and reduced side effects, tinidazole is an alternative agent for BV treatment. There are minimal head-to-head comparative data to establish tinidazole’s superiority to metronidazole or other therapeutic agents. Available data suggest tinidazole has a role in special populations particularly for refractory or relapsing BV.

Keywords: bacterial vaginosis, vaginosis, tinidazole, Gardnerella








Readers of this article also read:

Periosteoplasty for covering gingival recessions: Clinical results
Radiolucency below the crown of mandibular horizontal incompletely impacted third molars and acute inflammation in men with diabetes
Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors
Tinidazole in the treatment of bacterial vaginosis
Incretin-based therapies: new treatments for type 2 diabetes in the new millennium
Celecoxib in arthritis: relative risk management profile and implications for patients
The relationship between deliberate self-harm behavior, body dissatisfaction, and suicide in adolescents: current concepts
Differences in maintenance of mean blood glucose (BG) and their association with response to “recognizing hunger”
Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy
Erratum